Nanoparticles to Cross Biological Barriers - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 121

210. T. Tanaka, S. Shiramoto, M. Miyashita, Y. Fujishima, Y. Kaneo, Tumor target-
ing based on the effect of enhanced permeability and retention (EPR) and the
mechanism of receptor-mediated endocytosis (RME), Int. J. Pharm . 277 (2004)
39-61.
211. D. Schaffert, E. Wagner, Gene therapy progress and prospects: Synthetic polymer-
based systems, Gene Ther. 15 (2008) 1131-1138.
212. D. Shenoy, S. Little, R. Langer, M. Amiji, Poly(ethylene oxide)-modified
poly(β-amino ester) nanoparticles as a pH-sensitive system for tumor-
targeted delivery of hydrophobic drugs. 1. In Vitro Evaluations, Molecular
Pharmaceutics 2 (2005) 357-366.
213. J.E. Fuller, G.T. Zugates, L.S. Ferreira, H.S. Ow, N.N. Nguyen, U.B. Wiesner,
R.S. Langer, Intracellular delivery of core-shell fluorescent silica nanoparticles,
Biomaterials 29 (2008) 1526-1532.
214. H. Meng, M. Xue, T. Xia, Y. Zhao, F. Tamanoi, J.F. Stoddart, J.I. Zink, A.E. Nel,
Autonomous in vitro anticancer drug release from mesoporous silica nanopar-
ticles by pH-sensitive nanovalves, J. Am. Chem. Soc. 132 (2010) 12690-12697.
215. L.M. de la.Fuente, C.C. Berry, Tat peptide as an efficient molecule to translocate
gold nanoparticles into the cell nucleus, Bioconjug. Chem. 16 (2005) 1176-1180.
216. V. Weissig, G.G.M. D'Souza, S. Cheng, S. Boddapati, Mitochondrial Nanotechnology
for Cancer Therapy , (2009) 265-279.
217. S.V. Boddapati, G.G.M. D'Souza, S. Erdogan, V.P. Torchilin, V. Weissig, Organelle-
targeted nanocarriers: Specific delivery of liposomal ceramide to mitochondria
enhances its cytotoxicity in vitro and in vivo, Nano Letters 8 (2008) 2559-2563.
218. Y. Yamada, H. Akita, K. Kogure, H. Kamiya, H. Harashima, Mitochondrial drug
delivery and mitochondrial disease therapy: An approach to liposome-based
delivery targeted to mitochondria, Mitochondrion 7 (2007) 63-71.
219. C. Medina, M.J. Santos-Martinez, A. Radomski, O.I. Corrigan, M.W. Radomski,
Nanoparticles: Pharmacological and toxicological significance, British Journal of
Pharmacology 150 (2007) 552-558.
220. A.M. Smith, H. Duan, A.M. Mohs, S. Nie, Bioconjugated quantum dots for in
vivo molecular and cellular imaging, Adv. Drug Deliv. Rev. 60 (2008) 1226-1240.
221. H. Yamawaki, N. Iwai, Mechanisms underlying nano-sized air-pollution-
mediated progression of atherosclerosis, Circulation Journal 70 (2006) 129-140.
222. S.H. Yalkowsky, J.F. Krzyzaniak, G.H. Ward, Formulation-related problems
associated with intravenous drug delivery, Journal of Pharmaceutical Sciences
87 (1998) 787-796.